DR. REDDY'S LABORATORIES-ADR (RDY) Stock Price, Quote, News and Overview
NYSE:RDY - New York Stock Exchange, Inc. - US2561352038 - ADR - Currency: USD
RDY Quote, Performance and Key Statistics
14.33
-0.17 (-1.17%)
The current stock price of RDY is 14.33 USD. In the past month the price increased by 4.75%. In the past year, price increased by 3.05%.
RDY Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 52.69 | 687.25B | ||
| JNJ | JOHNSON & JOHNSON | 15.24 | 368.56B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 19.6 | 302.74B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.57 | 222.75B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.73 | 216.03B | ||
| MRK | MERCK & CO. INC. | 9.88 | 193.71B | ||
| PFE | PFIZER INC | 7.18 | 130.67B | ||
| SNY | SANOFI-ADR | 13.88 | 129.50B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.4 | 95.65B | ||
| GSK | GSK PLC-SPON ADR | 7.03 | 77.98B | ||
| ZTS | ZOETIS INC | 26.82 | 72.01B | ||
| HLN | HALEON PLC-ADR | 22.65 | 50.05B |
Related stock screener links
About RDY
Company Profile
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 26,343 full-time employees. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Company Info
DR. REDDY'S LABORATORIES-ADR
8-2-337, Road No.3 Banjara Hills
Hyderabad TELANGANA 500-034 IN
CEO: Erez Israeli
Employees: 27048
Phone: 914049002900
DR. REDDY'S LABORATORIES-ADR / RDY FAQ
What is the stock price of DR. REDDY'S LABORATORIES-ADR today?
The current stock price of RDY is 14.33 USD. The price decreased by -1.17% in the last trading session.
What is the ticker symbol for DR. REDDY'S LABORATORIES-ADR stock?
The exchange symbol of DR. REDDY'S LABORATORIES-ADR is RDY and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is RDY stock listed?
RDY stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for DR. REDDY'S LABORATORIES-ADR stock?
40 analysts have analysed RDY and the average price target is 16.06 USD. This implies a price increase of 12.04% is expected in the next year compared to the current price of 14.33. Check the DR. REDDY'S LABORATORIES-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DR. REDDY'S LABORATORIES-ADR worth?
DR. REDDY'S LABORATORIES-ADR (RDY) has a market capitalization of 11.92B USD. This makes RDY a Large Cap stock.
How many employees does DR. REDDY'S LABORATORIES-ADR have?
DR. REDDY'S LABORATORIES-ADR (RDY) currently has 27048 employees.
What are the support and resistance levels for DR. REDDY'S LABORATORIES-ADR (RDY) stock?
DR. REDDY'S LABORATORIES-ADR (RDY) has a support level at 14.09 and a resistance level at 14.45. Check the full technical report for a detailed analysis of RDY support and resistance levels.
Is DR. REDDY'S LABORATORIES-ADR (RDY) expected to grow?
The Revenue of DR. REDDY'S LABORATORIES-ADR (RDY) is expected to grow by 9.19% in the next year. Check the estimates tab for more information on the RDY EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DR. REDDY'S LABORATORIES-ADR (RDY) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RDY, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RDY, evaluating the profitability, health, valuation and growth aspects
- DR. REDDY'S LABORATORIES-ADR (RDY) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DR. REDDY'S LABORATORIES-ADR (RDY) Sales and EPS estimates to see what analysts future expectations are.
- DR. REDDY'S LABORATORIES-ADR (RDY) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DR. REDDY'S LABORATORIES-ADR (RDY) Insider and Institutional Ownership to learn about the owners and their transactions.
- DR. REDDY'S LABORATORIES-ADR (RDY) Stock Chart to make your own analysis
- DR. REDDY'S LABORATORIES-ADR (RDY) Latest news and press-releases to stay up to date.
Does DR. REDDY'S LABORATORIES-ADR (RDY) stock pay dividends?
DR. REDDY'S LABORATORIES-ADR (RDY) has a dividend yield of 0.65%. The yearly dividend amount is currently 0.09. Check the full fundamental report for a detailed analysis of RDY dividend history, reliability and sustainability.
What is the Price/Earnings (PE) ratio of DR. REDDY'S LABORATORIES-ADR (RDY)?
The PE ratio for DR. REDDY'S LABORATORIES-ADR (RDY) is 18.14. This is based on the reported non-GAAP earnings per share of 0.79 and the current share price of 14.33 USD. Check the full fundamental report for a full analysis of the valuation metrics for RDY.
What is the Short Interest ratio of DR. REDDY'S LABORATORIES-ADR (RDY) stock?
The outstanding short interest for DR. REDDY'S LABORATORIES-ADR (RDY) is 2.57% of its float. Check the ownership tab for more information on the RDY short interest.
RDY Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to RDY. When comparing the yearly performance of all stocks, RDY is one of the better performing stocks in the market, outperforming 73.29% of all stocks.
RDY Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to RDY. Both the health and profitability get an excellent rating, making RDY a very profitable company, without any liquidiy or solvency issues.
RDY Financial Highlights
Over the last trailing twelve months RDY reported a non-GAAP Earnings per Share(EPS) of 0.79. The EPS increased by 0.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.3% | ||
| ROA | 11.43% | ||
| ROE | 16.84% | ||
| Debt/Equity | 0.02 |
RDY Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 66% to RDY. The Buy consensus is the average rating of analysts ratings from 40 analysts.
For the next year, analysts expect an EPS growth of 7.88% and a revenue growth 9.19% for RDY